Brief: Avant Technologies And JV Partner, Ainnova, Prepare For Key FDA Milestone With Next Week's Pre-Submission Meeting
Avant Technologies Inc AVAI.PK: AVANT TECHNOLOGIES AND JV PARTNER, AINNOVA, PREPARE FOR KEY FDA MILESTONE WITH NEXT WEEK'S PRE-SUBMISSION MEETING AVANT TECHNOLOGIES INC - FDA PRE-SUBMISSION MEETING SET FOR JULY 7 Source text: ID:nCNWlKF42a Further company coverage: AVAI.PK
Recent news on Avai Bio
See all newsBrief: Avai Bio, Ainnova Tech terminate JV, license agreement on May 7, 2026 - SEC Filing
Brief: Avaí Bio And Austrianova Begin Production Of Master Cell Bank For Klotho Anti-Aging Therapy Under Gmp Standards
Brief: Avant Technologies And JV Partner, Ainnova, Prepare For Key FDA Milestone With Next Week's Pre-Submission Meeting
Brief: Avant Technologies Signs Letter Of Intent For A Business Combination
Brief: Avant Technologies And Ainnova Tech Begin Acquisition Talks